The Oncology Nursing Society has compiled a library of a variety of resources to help nurses understand drug development and stay up to date on the latest FDA approvals.
Episode 275: Bispecific Monoclonal Antibodies in Hematologic Cancers and Solid Tumors
Episode 273: Updates in Chemotherapy and Immunotherapy
Episode 260: Diversity in Cancer Clinical Trials
Episode 245: Biosimilar Basics for Oncology Nurses and Patients
Episode 242: Oncology Pharmacology 2023: Today’s Treatments and Tomorrow’s Breakthroughs
FDA’s Role in Postmarketing Drug Safety Surveillance (FREE 1 hour CE credit) - Expires 12/31/24
How FDA and ISMP Utilize Medication Error Reports to Improve Drug Safety (FREE 1 hour CE credit) - Expires 12/31/24
Drug Shortages: Root Causes and Potential Solutions (FREE 1 hour CE credit) - Expires 06/28/25
FDA Drug Information Resources and Applicability to Health Care Professionals (FREE 1 hour CE credit) - Expires 12/31/24
The Ins and Outs of Prescription Drug Labeling (FREE 1 hour CE credit) - Expires 12/31/24
Overview of Expanded Access (EA) Program and EA eRequest Site (FREE 1 hour CE credit) - Expires 12/31/24
Counseling Patients on Generic Drugs (FREE 1 hour CE credit) - Expires 12/31/24
Full list of FDA Online Learning offerings
Project Livin’ Label is an educational offering that aims to help learners understand oncology product labels and increase awareness of recent oncology drug FDA approvals. Each episode is FREE and offers NCPD credit. Available episodes cover venetoclax, pembrolizumab, fam-trastuzumab deruxtecan-nxki and more!
What New Cancer Drugs Were Approved in 2023?
FDA Oncology (Cancer)/Hematologic Malignancies Approval Notifications
FDA Alerts Subscription - Sign up for immediate, daily, or weekly FDA alerts via email by visiting this website.
The National Institute for Occupational Safety and Health (NIOSH)
NCI: Off-Label Drug Use in Cancer Treatment
NCI: Ways to Access Experimental Cancer Drugs
Approved Risk Evaluation and Mitigation Strategies (REMS)
The Cancer Research Institute (CRI) Timeline- Funding 70 Years of Discovery in Cancer Immunotherapy
The Cancer Research Institute (CRI) FY2023 Impact Report Infographic
The Cancer Research Institute (CRI) FY2023 Highlights and Accomplishments
Drug Shortages in Oncology: ASCO Clinical Guidance for Alternative Treatments
Enhanced Drug Distribution Security: 2023 and Beyond (FREE 1 hour CE credit) - Expires 12/31/24
Artificial intelligence in drug discovery and development
Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: A Review
Collections of topic-specific content curated to catalog education and resources on a similar topic.
View All Learning Libraries